Woodline Partners »

Pacific Biosciences of California shares owned by Woodline Partners

Quarter-by-quarter ownership of Pacific Biosciences of California (PACB) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Pacific Biosciences of California

Tip: Access up to 7 years of quarterly data

All positions including Pacific Biosciences of California held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacific Biosciences of California by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.8M 1.5M 3.75
2023-09-30 $20M 2.4M 8.35
2023-06-30 $11M 801k 13.30
2023-03-31 $7.0M 608k 11.58

More positions owned by Woodline Partners

Eli Lilly & Co. (LLY)
Te Connectivity SHS (TEL)
Regeneron Pharmaceuticals (REGN)
Encana Corporation (OVV)
Analog Devices (ADI)
Avnet (AVT)
Merck & Co (MRK)
Revolution Medicines (RVMD)
Zimmer Holdings (ZBH)
Meta Platforms Cl A (META)
Roivant Sciences SHS (ROIV)
Abbvie (ABBV)
Enerplus Corp (ERF)
Permian Resources Corp Class A Com (PR)
Amazon (AMZN)

View all positions for Woodline Partners

Top funds holding Pacific Biosciences of California

ARK Investment Management
Vanguard Group
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Bank of New York Mellon
Edmond De Rothschild Holding
T. Rowe Price Investment Management
Jackson Square Partners
Geode Capital Management
Bellevue Group
Farallon Capital Management
Dimensional Fund Advisors
Decheng Capital
VK Services

View all funds holding Pacific Biosciences of California